Bombay HC directs Maharashtra FDA to withdraw Cipla licence cancellation order
Court questions FDA’s handling of proceedings and directs regulator to issue fresh show-cause notice and conduct hearing on a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Maharashtra FDA
Pharma Live Expo & Summit 2024 concludes successfully in Mumbai
Industry leaders congregate to showcase advancements, highlight opportunities, draw roadmap for growth in the sector
Government should make IP certification mandatory for IPAs used in pharma industry
Vikas Biyani, Retired Assistant Commissioner, Maharashtra FDA, explains why it is critical to mandate the use of IPA with the…
Maha FDA seizes 15 vials of tocilizumab black marketed at Rs one lakh each
FIR filed against the accused, authorities find that he procured medicines from Delhi
Maha FDA files FIR against five people, guilty in blackmarketing of remedisivir and tocilizumab
The team seized medicines worth Rs 3,13,482 for COVID-19 and other therapeutic categories
Amidst the rise of COVID-19 positive…
Six people tests coronavirus positive in Maha FDA
A majority of them contracted the virus during field visits
Mumbai, Thane to get 60 per cent of Maharashtra’s remdesivir stock
It is likely that Cipla and Hetero Healthcare will supply 9000 vials and 12500 vials of remdesivir, respectively, to the State…
Sovereign Pharma releases first batch of remdesivir to Cipla
Cipla is likely to launch Cipremi in two to three days
Dept of Consumer Affairs withdraws masks, hand sanitisers from Essential Commodities Act
Public health activists raise concerns about the move and demand that the decision should be reconsidered
Hand sanitisers to be sold in licensed selling premises only: Maharashtra FDA
Earlier, Hindustan Unilever has sought clarification on the matter from Maharashtra FDA